ReviewFrontiers in immunology2023

Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy.

Zoya Kurago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.